ZTS Zoetis

  • Official Name: ZOETIS INC.
  • Headquarters: 10 Sylvan Way, PARSIPPANY, NJ, 07054 US
  • CEO: Kristin C. Peck
  • Website: zoetis.com

Match Results

Date League Week Opponent Result Score
2025-07-15 1 Lost by 1.927 (1.453) - 0.474
2025-07-15 1R Won by 0.079 (1.139) - (1.218)
2025-07-16 1R Lost by 0.240 (0.079) - 0.161
2025-07-22 2 Won by 3.178 1.019 - (2.159)
2025-07-29 3 Won by 1.677 0.185 - (1.492)
2025-07-29 2R Won by 1.432 0.424 - (1.008)
2025-08-05 4 Lost by 0.313 (1.264) - (0.951)
2025-08-07 1R Won by 1.057 1.216 - 0.159
2025-08-12 5 Won by 2.717 4.280 - 1.563
2025-08-12 3R Lost by 1.468 0.450 - 1.918
2025-08-19 6 Won by 2.014 3.150 - 1.136
2025-08-21 2R Won by 0.117 (0.795) - (0.912)
2025-08-26 7 Lost by 3.755 (0.528) - 3.227
2025-09-02 8 Won by 1.971 (1.350) - (3.321)
2025-09-04 3R Won by 0.028 0.515 - 0.487
2025-09-09 9 Won by 4.188 (2.170) - (6.358)
2025-09-11 4R Lost by 0.997 0.860 - 1.857
2025-09-16 10 Won by 0.604 (1.772) - (2.376)
2025-09-23 11 Lost by 5.878 (3.358) - 2.520
2025-09-30 12 Won by 0.624 2.427 - 1.803
2025-10-07 13 Lost by 2.884 (2.160) - 0.724
2025-10-14 14 Won by 2.599 0.410 - (2.189)
2025-10-21 15 Won by 5.112 1.801 - (3.311)

Latest News

Benzinga - 2026-10-16

Goldman Sachs Initiates Coverage On Zoetis with Neutral Rating, Announces Price Target of $74 🔗

Goldman Sachs analyst Matt Dellatorre initiates coverage on Zoetis (NYSE:ZTS) with a Neutral rating and announces Price Target of $74.

Zoetis (ZTS) Hit by Guidance Cuts, Met with Market Shrug
Yahoo - 2026-10-15

Zoetis (ZTS) Hit by Guidance Cuts, Met with Market Shrug 🔗

Middle Coast Investing, an investment advisor firm, released its second-quarter 2026 investor letter. The letter can be downloaded here. Market breadt...

3 Reasons ZTS is Risky and 1 Stock to Buy Instead
Yahoo - 2026-10-15

3 Reasons ZTS is Risky and 1 Stock to Buy Instead 🔗

Zoetis has gotten torched over the last six months - since April 2026, its stock price has dropped 37.6% to $75.34 per share. This was partly due to i...

Zoetis (NYSE:ZTS): A Quality Investing Case Study in Animal Health
ChartMill - 2026-10-14

Zoetis (NYSE:ZTS): A Quality Investing Case Study in Animal Health 🔗

Zoetis quality investing analysis: high ROIC, strong cash flow, low debt, reasonable valuation, but revenue growth lags Caviar Cruise screen criteria.

Zoetis (ZTS) Board Update And Dividend Keep Undervalued Narrative In Focus
Yahoo - 2026-10-14

Zoetis (ZTS) Board Update And Dividend Keep Undervalued Narrative In Focus 🔗

Board appointment and dividend set the stage for Zoetis Zoetis (ZTS) has given investors fresh governance and income headlines in October, with Iris K...

Branded Pharmaceuticals Stocks Q2 In Review: Zoetis (NYSE:ZTS) Vs Peers
Yahoo - 2026-10-13

Branded Pharmaceuticals Stocks Q2 In Review: Zoetis (NYSE:ZTS) Vs Peers 🔗

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are ...

Zoetis Appoints Iris Knobloch to its Board of Directors
Yahoo - 2026-10-13

Zoetis Appoints Iris Knobloch to its Board of Directors 🔗

PARSIPPANY, N.J., October 13, 2026--Zoetis Inc. (NYSE:ZTS) today announced the appointment of Iris Knobloch to its Board of Directors, effective as of...

10 Dividend Growth Stocks: October 2026
SeekingAlpha - 2026-10-11

10 Dividend Growth Stocks: October 2026 🔗

An equally weighted portfolio of the top 10 stocks yields 2.8% but would have underperformed SPY over the past 5 years. Check out dividend growth stoc...

Show more
SeekingAlpha - 2026-06-27

Neogen: Still A Difficult Story 🔗